282 related articles for article (PubMed ID: 22144895)
21. PrP(CWD) lymphoid cell targets in early and advanced chronic wasting disease of mule deer.
Sigurdson CJ; Barillas-Mury C; Miller MW; Oesch B; van Keulen LJM; Langeveld JPM; Hoover EA
J Gen Virol; 2002 Oct; 83(Pt 10):2617-2628. PubMed ID: 12237446
[TBL] [Abstract][Full Text] [Related]
22. The prion gene complex encoding PrP(C) and Doppel: insights from mutational analysis.
Mastrangelo P; Westaway D
Gene; 2001 Sep; 275(1):1-18. PubMed ID: 11574147
[TBL] [Abstract][Full Text] [Related]
23. The effects of host age on follicular dendritic cell status dramatically impair scrapie agent neuroinvasion in aged mice.
Brown KL; Wathne GJ; Sales J; Bruce ME; Mabbott NA
J Immunol; 2009 Oct; 183(8):5199-207. PubMed ID: 19786551
[TBL] [Abstract][Full Text] [Related]
24. Unaltered intravenous prion disease pathogenesis in the temporary absence of marginal zone B cells.
Bradford BM; Mabbott NA
Sci Rep; 2019 Dec; 9(1):19119. PubMed ID: 31836813
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional modulation in a leukocyte-depleted splenic cell population during prion disease.
Huzarewich RL; Medina S; Robertson C; Parchaliuk D; Booth SA
J Toxicol Environ Health A; 2011; 74(22-24):1504-20. PubMed ID: 22043911
[TBL] [Abstract][Full Text] [Related]
26. PrP expression, PrPSc accumulation and innervation of splenic compartments in sheep experimentally infected with scrapie.
Sørby R; Austbø L; Press CM; Skretting G; Landsverk T; Espenes A
PLoS One; 2009 Sep; 4(9):e6885. PubMed ID: 19727393
[TBL] [Abstract][Full Text] [Related]
27. Subclinical prion disease induced by oral inoculation.
Thackray AM; Klein MA; Bujdoso R
J Virol; 2003 Jul; 77(14):7991-8. PubMed ID: 12829838
[TBL] [Abstract][Full Text] [Related]
28. Selective neuronal targeting in prion disease.
DeArmond SJ; Sánchez H; Yehiely F; Qiu Y; Ninchak-Casey A; Daggett V; Camerino AP; Cayetano J; Rogers M; Groth D; Torchia M; Tremblay P; Scott MR; Cohen FE; Prusiner SB
Neuron; 1997 Dec; 19(6):1337-48. PubMed ID: 9427256
[TBL] [Abstract][Full Text] [Related]
29. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
[TBL] [Abstract][Full Text] [Related]
30. Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrP(Sc) and prion infectivity.
Krasemann S; Neumann M; Szalay B; Stocking C; Glatzel M
J Gen Virol; 2013 Feb; 94(Pt 2):453-463. PubMed ID: 23136363
[TBL] [Abstract][Full Text] [Related]
31. PrP expression and replication by Schwann cells: implications in prion spreading.
Follet J; Lemaire-Vieille C; Blanquet-Grossard F; Podevin-Dimster V; Lehmann S; Chauvin JP; Decavel JP; Varea R; Grassi J; Fontès M; Cesbron JY
J Virol; 2002 Mar; 76(5):2434-9. PubMed ID: 11836421
[TBL] [Abstract][Full Text] [Related]
32. Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells.
Mouillet-Richard S; Nishida N; Pradines E; Laude H; Schneider B; Féraudet C; Grassi J; Launay JM; Lehmann S; Kellermann O
J Biol Chem; 2008 Aug; 283(35):23782-90. PubMed ID: 18617522
[TBL] [Abstract][Full Text] [Related]
33. Prion uptake in the gut: identification of the first uptake and replication sites.
Kujala P; Raymond CR; Romeijn M; Godsave SF; van Kasteren SI; Wille H; Prusiner SB; Mabbott NA; Peters PJ
PLoS Pathog; 2011 Dec; 7(12):e1002449. PubMed ID: 22216002
[TBL] [Abstract][Full Text] [Related]
34. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
35. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
36. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
[TBL] [Abstract][Full Text] [Related]
37. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
38. Small is not beautiful: antagonizing functions for the prion protein PrP(C) and its homologue Dpl.
Behrens A; Aguzzi A
Trends Neurosci; 2002 Mar; 25(3):150-4. PubMed ID: 11852147
[TBL] [Abstract][Full Text] [Related]
39. Inducible expression of chimpanzee prion protein (PrP) in murine PrP knock-out cells.
Heinig L; Mueller DA; Ramljak S; Holznagel E; Stuke AW
Protein Expr Purif; 2010 Apr; 70(2):129-36. PubMed ID: 19796688
[TBL] [Abstract][Full Text] [Related]
40. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
